Zheng, L., Chen, L., Liao, X., Xu, Z., Chen, Z., & Sun, J. (2018). Case report: Primary resistance to osimertinib in erlotinib-pretreated lung adenocarcinoma with EGFR T790 M mutation. BMC Cancer.
Παραπομπή Chicago StyleZheng, Lin-Peng, Li-Ying Chen, Xing-Yun Liao, Zi-Han Xu, Zheng-Tang Chen, και Jian-Guo Sun. "Case Report: Primary Resistance to Osimertinib in Erlotinib-pretreated Lung Adenocarcinoma With EGFR T790 M Mutation." BMC Cancer 2018.
Παραπομπή MLAZheng, Lin-Peng, et al. "Case Report: Primary Resistance to Osimertinib in Erlotinib-pretreated Lung Adenocarcinoma With EGFR T790 M Mutation." BMC Cancer 2018.
Πρόσοχή: Οι παραπομπές μπορεί να μην είναι 100% ακριβείς.